Insulet Corporation (NASDAQ: PODD) kicked off on Monday, up 4.47% from the previous trading day, before settling in for the closing price of $245.26. Over the past 52 weeks, PODD has traded in a range of $160.19-$289.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 22.98% over the past five years. While this was happening, its average annual earnings per share was recorded 30.28%. With a float of $69.90 million, this company’s outstanding shares have now reached $70.20 million.
Let’s look at the performance matrix of the company that is accounted for 3900 employees. In terms of profitability, gross margin is 76.41%, operating margin of 16.26%, and the pretax margin is 15.8%.
Insulet Corporation (PODD) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Insulet Corporation is 0.47%, while institutional ownership is 101.80%. The most recent insider transaction that took place on Mar 25 ’25, was worth 501,875. In this transaction Director of this company sold 1,825 shares at a rate of $275.00, taking the stock ownership to the 3,231 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Director proposed sale 1,825 for $275.00, making the entire transaction worth $501,875.
Insulet Corporation (PODD) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.89 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.40% during the next five years compared to 98.82% growth over the previous five years of trading.
Insulet Corporation (NASDAQ: PODD) Trading Performance Indicators
Take a look at Insulet Corporation’s (PODD) current performance indicators. Last quarter, stock had a quick ratio of 2.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.69. Likewise, its price to free cash flow for the trailing twelve months is 58.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.79, a number that is poised to hit 0.79 in the next quarter and is forecasted to reach 5.27 in one year’s time.
Technical Analysis of Insulet Corporation (PODD)
Insulet Corporation (NASDAQ: PODD) saw its 5-day average volume 1.04 million, a positive change from its year-to-date volume of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 33.82%. Additionally, its Average True Range was 11.72.
During the past 100 days, Insulet Corporation’s (PODD) raw stochastic average was set at 44.07%, which indicates a significant decrease from 49.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.53% in the past 14 days, which was higher than the 30.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $269.37, while its 200-day Moving Average is $241.09. Nevertheless, the first resistance level for the watch stands at $266.09 in the near term. At $275.94, the stock is likely to face the second major resistance level. The third major resistance level sits at $290.64. If the price goes on to break the first support level at $241.54, it is likely to go to the next support level at $226.84. Assuming the price breaks the second support level, the third support level stands at $216.99.
Insulet Corporation (NASDAQ: PODD) Key Stats
The company with the Market Capitalisation of 17.99 billion has total of 70,226K Shares Outstanding. Its annual sales at the moment are 2,072 M in contrast with the sum of 418,300 K annual income. Company’s last quarter sales were recorded 597,500 K and last quarter income was 100,700 K.
